Participants’ characteristics and baseline drinking prior to treatment entry for Study 1 and 2 are summarized in Table 1. Consistent with previous patient treatment based daily diary research, adherence to daily reporting during the target data collection phase while in treatment to all possible assessments was 73.0% in Study 1 and 77.5% in Study 2 (Litt et al., 1998). In Study 1, participants completed a total of 903 daily logs of which 42.1% were drinking days (M=4.49, SD=4.15 days, range: 0–14 days). The average number of drinks consumed on drinking days were 4.96±6.94. Stressful events occurred on 35.2% assessed days, and the average daily craving was 1.59±1.25 on the 5-point scale. In Study 2, participants completed approximately 1488 daily logs of which 29.9% were drinking days (M=15.93, SD=16.12 days, range: 0–50). On drinking days, participants drank approximately 4.17±2.84 drinks on average (1–14.32). Stressful events occurred on 43.2% of the days recorded, and the average craving on the VAS scale was 31.19±30.80. The Supplemental Appendix includes additional descriptive results. All results described in the following sections included all the covariates, and inclusion of these covariates did not change the pattern of results.
